CN Patent

CN112165958A — 调制激酶的化合物的制剂

Assigned to Presico · Expires 2021-01-01 · 5y expired

What this patent protects

提供了具有下式的化合物I的固体分散体、制备所述固体分散体的方法和使用所述固体分散体的方法：其中化合物I基本上是无定形的。

USPTO Abstract

提供了具有下式的化合物I的固体分散体、制备所述固体分散体的方法和使用所述固体分散体的方法：其中化合物I基本上是无定形的。

Drugs covered by this patent

umbralisib-tosylate (UMBRALISIB TOSYLATE)

Patent Metadata

Patent number: CN112165958A
Jurisdiction: CN
Classification: —
Expires: 2021-01-01
Drug substance claim: No
Drug product claim: No
Assignee: Presico
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.